Health. Innovation. Experience.
We operate at the intersection of public policy, business strategy, and government affairs.
Healthsperien, LLC, is a nationally-recognized health care policy consulting firm focused on federal and state regulatory and legislative policy analysis, advocacy, and implementation issues.
Our mission is to accelerate responsible and sustainable health care system innovation and transformation to improve health outcomes for all, and especially the most vulnerable.
Our team serves clients at the intersection of public policy, business strategy, and government affairs, and we are dedicated to helping organizations navigate the complexities and challenges of health care policy, politics, and regulation.
Offerings & Expertise
Featured News & Resources
Weekly Roundup: May 12, 2023
Inside this Edition Healthsperien Coverage of Senate HELP Hearing on Insulin and PBMs | CMS Releases FAQ Sheet on the Expiring Continuous Enrollment Condition | FDA Approves First Drug to Treat Agitation Symptoms Associated with Alzheimer’s Disease | Executive Action | Regulatory Action | Congressional Action | Medicare | Medicaid | Research Our team of experts at Healthsperien are proactively working to support your …
Weekly Roundup: May 5, 2023
Inside this Edition Coalition to End Social Isolation & Loneliness Holds Annual Connections at the Capitol | Biden Administration Announces Executive Leadership Changes | KFF Report Highlights Tough Tradeoffs Under Republican Work Requirement Plan | Executive Action | Administrative Action | Regulatory Action | Congressional Action | Medicaid | Research Our team of experts at Healthsperien are proactively working to support your organization’s ongoing strategic …
Healthsperien’s Coverage of HHS Budget Hearing
On March 28th, HHS Secretary Xavier Becerra testified before the House Ways & Means Committee and fielded questions on President Biden’s FY 2024 HHS budget proposal. After Secretary Becerra’s testimony, he faced questions from representatives on a wide range of topics, including the Medicare Advantage Advance Notice, the drug price negotiation process, implementation of the No Surprises Act, and coverage …
HHS Secretary Becerra Testifies Before Senate Finance Committee on President Biden’s FY 2024 Proposed Budget
On March 22, HHS Secretary Xavier Becerra testified before the Senate Finance Committee and fielded questions on President Biden’s FY 2024 budget proposal. Following Secretary Becerra’s testimony, Senators asked questions related to Medicare Advantage (MA), the Inflation Reduction Act (IRA) and drug price negotiation, Pharmacy Benefit Manager (PBMs), surprise billing, and Alzheimer’s treatment. Specifically, Senate Finance and Appropriations members called on …